Health

ExpressCells and Funakoshi Establishes Japanese Distribution Agreement

December 22, 2021

ExpressCells, Inc., a genetic engineering company that creates genetically edited cell lines for research and production, and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells’ products in Japan. The agreement brings together two companies advancing innovation by […]

Avanos Medical To Acquire OrthogenRx for $160 Million

December 15, 2021

Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire OrthogenRx, Inc., an emerging leader in viscosupplementation therapies for the treatment of knee osteoarthritis (OA) pain, for a total consideration of $160 million. The purchase price consists of $130 million in cash at closing plus an additional $30 million […]

Revolutionizing the Manufacture of Medicine and More

December 2, 2021

Making new drugs, vaccines and gene therapy can take up to a decade or longer, and cost hundreds of millions of dollars or more. The process is complex and it requires many steps to go from conception to market. And a new platform from ChromaTan, a startup with roots in Happy Valley, is poised to […]

How Can Entrepreneurs Tackle Health Inequities with Tech Solutions?

December 1, 2021

Tennis icon Serena Williams was vocal about her difficulties as a Black woman who experienced a scary childbirth. Track and field star Allyson Felix also spoke out about the life-threatening complications she faced during her pregnancy. While these mothers — both wealthy celebrities — had access to financial resources and support to assist them during […]

6 Philadelphia-Area Companies Land on Deloitte’s 2021 Technology Fast 500 List

November 17, 2021

Six companies in Greater Philadelphia rank among the 500 fastest-growing technology and life sciences companies in North America, according to a new report from Deloitte. Deloitte’s 2021 Technology Fast 500 Rankings, released Wednesday, rank firms based on revenue growth percentage during the period from 2017 to 2020. Qualifying companies had to have operating revenue of […]

Why it Matters That Ben Franklin Tech Partners’ New Team Brings Clinical Experience to Healthcare Investing

November 10, 2021

Ben Franklin Technology Partners of Southeastern Pennsylvania has formed an investment group to support the development of early-stage companies focused on health care technologies and outcomes. The four-person health care investment team will led by Jennifer Hartt, who will serve as its managing director. Since 2006, Hartt has closed more than 150 investments totaling about […]

Why it Matters That Ben Franklin Tech Partners’ New Team Brings Clinical Experience to Healthcare Investing

November 10, 2021

Often times it is the people closest to problems who best understand the solutions. That’s why state-backed seed and early-stage funder Ben Franklin Technology Partners has brought on pros with direct experience in the healthcare field to lead its new Healthcare Investment Group (HIG). HIG Managing Director Jennifer Hartt, Ben Franklin’s former director of investments […]

3 Philadelphia Startups Land Six-Figure Investments in PACT’s ‘Lion’s Den’

November 8, 2021

Three Philadelphia-area startups secured hundreds of thousands of dollars in growth capital from The Lion’s Den, a “Shark Tank”-like production hosted by local investors. Dozens of local startup founders, from early-stage companies to fast-growing technology and life sciences firms, pitched their ventures during the Philadelphia Alliance for Capital and Technologies’ 2021 Capital Conference on Thursday […]

Navrogen Enters Into CRADA With USAMRIID To Test Proprietary Small Molecule NK Cell Activators Against SARS-COV-2 Infection

September 16, 2021

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The CRADA is focused on testing Navrogen’s small molecule NK cell activating agents on suppressing propagation of SARS-COV-2. Researchers […]

Navrogen Raises $3M in Venture Capital Financing to Advance Cancer Therapy Platform

September 3, 2021

A 4-year-old biotechnology company based on the campus of Cheyney University of Pennsylvania has raised $3 million in a venture capital financing. Navrogen Inc. plans to use the proceeds from the seed funding round to support its technology platform being used to develop potential new therapies targeting immunosuppressed cancers and immune-mediated diseases. The financing was […]